ArticleFrontiers in oncology2022

Real World Overall Survival of Patients With Metastatic Renal Cell Carcinoma Treated With Only Available Sunitinib and Pazopanib in First-Line Setting.

Predrag Nikic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.